Elevated NT-proBNP levels should be interpreted in elderly patients presenting with dyspnea

European Journal of Internal Medicine

Volumn 22, Issue 1, 2011, Pages 108-111

  Fabbian, Fabio ^a   De Giorgi, Alfredo ^a   Pala, Marco ^a   Tiseo, Ruana ^a   Portaluppi, Francesco ^a  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

Chronic heart; Congestive heart failure; Dyspnea; Elderly; Natriuretic factors; NT proBNP; Renal failure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN;

AGED; ANAMNESIS; ANTHROPOMETRIC PARAMETERS; ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; DYSPNEA; ELDERLY CARE; FEMALE; HOSPITAL ADMISSION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE;

AGED; AGED, 80 AND OVER; ALGORITHMS; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; DYSPNEA; FEMALE; HUMANS; LOGISTIC MODELS; LUNG DISEASES; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 78751575593     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2010.07.013     Document Type: Article

References (32)

1. A.J. De Bold, B.G. Bruneau, and M.L. Kuroski de Bold Mechanical and neuroendocrine regulation of the endocrine heart, review Cardiovas Res 31 1996 7 18
2. I. Loke, I.B. Sqire, J.E. Davies, and L.L. Ng Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate Eur J Heart Fail 5 2003 599 606
3. D.G. Krauser, D.M. Lloyd-Jones, C.U. Chae, R. Cameron, S. Anwaruddin, and A.L. Baggish Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy Am Heart J 149 2005 744 750
4. L.B. Daniels, and A.S. Maisel Natriuretic peptides J Am Coll Cardiol 50 2007 2357 2368
5. Y. Mizuno, M. Yoshimura, E. Harada, M. Nakayama, T. Sakamoto, and Y. Shimasaki Plasma levels of A- and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy Am J Cardiol 86 2000 1036 1040
6. G. Takemura, Y. Takatsu, K. Doyama, H. Itoh, Y. Saito, and M. Koshiji Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis J Am Coll Cardiol 31 1998 754 765
7. M.A. Burke, and W.G. Cotts Interpretation of B-type natriuretic peptide in cardiac disease and other co-morbidity condition Heart Fail Rev 12 2007 23 36
8. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J.V. McMurray, P. Ponikowski, and P.A. Poole-Wilson ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 Eur Heart J 29 2008 2388 2442
9. C. Stenton The MRC breathlessness scale Occup Med 58 2008 226 227
10. A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro III, and H.I. Feldman CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
11. National Kideny Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 36 Suppl 1 2002 S1 S266
12. J.L. Januzzi Natriuretic peptide testing: a window into the diagnosis and prognosis of heart failure Cleve Clin J Med 73 2006 149 157
13. A. Clerico, M. Fontana, A. Ripoli, and M. Emdin Clinical relevance of BNP measurement in the follow-up of patient with chronic heart failure Adv Clin Chem 48 2009 163 179
14. P.M. Mc Kie, and J.C. Burnett Jr. B-type natriuretic peptide as a biomarker beyond heart failure: speculations and opportunities Mayo Clin Proc 80 2005 1029 1036
15. A. Mansoor, K. Althoff, S. Gange, K. Anastos, J. Dehovitz, and H. Minkoff Elevated NT-pro-BNP levels are associated with co-morbidities among HIV-infected women AIDS Res Hum Retroviruses 25 10 2009 997 1004
16. R.K. Rogers, G.J. Stoddard, T. Greene, A.D. Michaels, G. Fernandez, and A. Freeman Usefulness of adjusting for clinical covariates to improve the ability of B-type natriuretic peptide to distinguish cardiac from non-cardiac dyspnea Am J Cardiol 104 5 2009 689 694
17. D. Kondziella, M. Göthlin, M. Fu, H. Zetterberg, and A. Wallin B-type natriuretic peptide plasma levels are elevated in subcortical vascular dementia NeuroReport 20 9 2009 825 827
18. M. Barents, H.H. Hillege, I.C. van der Horst, R.A. de Boer, J. Koster, and F.A. Muskeit BNP and NT-proBNP, predictors of 1-year mortality in nursing home residents J Am Med Dir Assoc 9 8 2008 580 585
19. S. Biasioli, M. Zamperetti, D. Borin, G. Guidi, E. De Fanti, and R. Schiavon Significance of plasma B-type natriuretic peptide in hemodialysis patients: blood sample timing and co-morbidity burden ASAIO J 53 5 2007 587 591
20. C. Longhini, C. Molino, and F. Fabbian Cardiorenal syndrome: still not a defined entity Clin Exp Nephrol 14 2010 12 21
21. S.C. Burjonroppa, A.T. Tong, L.C. Xiao, M.M. Johnson, S.W. Yusuf, and D.J. Lenihan Cancer patients with markedly elevated B-type natriuretic peptide may not have volume overload Am J Clin Oncol 30 3 2007 287 293
22. V. Jeevananthan, R. Shrivastava, S. Nannapaneni, A. Khan, M. Sengodan, and A. Nautiyal Evaluated B-type natriuretic peptide level: use with caution in patients with multiple co-morbidities and presenting with dyspnea Indian Heart J 59 2007 64 68
23. H.H. Leuchte, C. Neurohr, R. Baumgartner, M. Holzapfel, W. Giehrl, and M. Vogeser Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension Am J Respir Crit Care Med 170 4 2004 360 365 (Pubitemid 39214607)
24. N. Nagaya, T. Nishikimi, Y. Okano, M. Uematsu, T. Satoh, and S. Kyotani Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension J Am Coll Cardiol 31 1 1998 202 208 (Pubitemid 28064743)
25. L.B. Yap, D. Mukerjee, P.M. Timms, H. Ashrafian, and J.G. Coghlan Natriuretic peptides, respiratory disease, and the right heart Chest 126 4 2004 1330 1336
26. C. Terzano, V. Conti, F. Di Stefano, A. Petroianni, D. Ceccarelli, and E. Graziani Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study Lung 188 4 2010 321 329
27. F. Pieralli, I. Olivotto, S. Vanni, A. Conti, A. Camaiti, and G. Targioni Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism Am J Cardiol 97 2006 1386 1390
28. C. Mueller, K. Laule-Kilian, B. Frana, D. Rodriguez, A. Scholer, and C. Schindler Use of B-type natriuretic peptide in the management of acute dyspnea in patients with pulmonary disease Am Heart J 151 2006 471 477 (Pubitemid 43144752)
29. S. Krüger, J. Graf, M.W. Merx, K.C. Koch, D. Kunz, and P. Hanrath Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism Am Heart J 147 2004 60 65 (Pubitemid 38037398)
30. J.N. Cohn B-type natriuretic peptide level had reduced specificity for diagnosing heart failure in dyspnea with atrial fibrillation in the emergency department ACP J Club 144 2006 48
31. T. Similowski, A. Agusti, W. MacNee, and B. Schönhofer The potential impact of anaemia of chronic disease in COPD Eur Respir J 27 2006 390 396
32. P. Porapakkham, P. Porapakkham, H. Zimmet, B. Billah, and H. Krum B-type natriuretic peptide-guided heart failure therapy Arch Intern Med 170 2010 507 514